These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29126273)

  • 41. [Membranous nephropathy: Pathophysiology and natural history].
    Seitz-Polski B; Lambeau G; Esnault V
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S75-S81. PubMed ID: 28577747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A
    Tominaga K; Uchida T; Imakiire T; Itoh K; Shimazaki H; Nakanishi K; Kumagai H; Oshima N
    BMC Nephrol; 2018 May; 19(1):120. PubMed ID: 29792176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associations between m-type phospholipase A2 receptor,human leukocyte antigen gene polymorphisms and idiopathic membranous nephropathy.
    Liu X; Xu W; Yu C; Wang M; Liu R; Xie R
    Bioengineered; 2021 Dec; 12(1):8833-8844. PubMed ID: 34607530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of SNPs in
    Tian CX; Li L; Qiu P; Qiu YR
    Br J Biomed Sci; 2020 Jan; 77(1):24-28. PubMed ID: 31532353
    [No Abstract]   [Full Text] [Related]  

  • 45. Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy.
    Mahmud M; Pinnschmidt HO; Reinhard L; Harendza S; Wiech T; Stahl RAK; Hoxha E
    PLoS One; 2019; 14(9):e0221293. PubMed ID: 31498806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-130a-5p prevents angiotensin II-induced podocyte apoptosis by modulating M-type phospholipase A2 receptor.
    Liu D; Liu F; Wang X; Qiao Y; Pan S; Yang Y; Hu Y; Zhang Y; Tian F; Liu Z
    Cell Cycle; 2018; 17(21-22):2484-2495. PubMed ID: 30394845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrent membranous nephropathy after transplantation: donor antigen and HLA converge in defining risk.
    Robson KJ; Kitching AR
    Kidney Int; 2021 Mar; 99(3):545-548. PubMed ID: 33637201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic variants in membranous nephropathy: perhaps a perfect storm rather than a straightforward conformeropathy?
    Salant DJ
    J Am Soc Nephrol; 2013 Mar; 24(4):525-8. PubMed ID: 23492731
    [No Abstract]   [Full Text] [Related]  

  • 49. A case of membranous nephropathy characterized by atypical distribution of phospholipase A2 receptor
.
    Hyodo T; Saito K; Kono K; Nishi S; Itoh T; Hara S
    Clin Nephrol; 2019 Feb; 91(2):114-119. PubMed ID: 30474595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating (CD3(-)CD19(+)CD20(-)IgD(-)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?
    Pozdzik A; Beukinga I; Gu-Trantien C; Willard-Gallo K; Nortier J; Pradier O
    Mediators Inflamm; 2016; 2016():7651024. PubMed ID: 27493452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype.
    Hara S; Goto S; Kamiura N; Yoshimoto A; Naito T; Imagawa N; Imai Y; Yanagita M; Nishi S; Itoh T
    Virchows Arch; 2015 Jul; 467(1):87-94. PubMed ID: 25820371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Pathogenesis of Membranous Nephropathy.
    Ronco P; Debiec H
    Annu Rev Pathol; 2020 Jan; 15():287-313. PubMed ID: 31622560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of serum levels of anti-phospholipase A2 receptor antibodies in the diagnosis of primary membranous nephropathy.
    Ronchev Y; Terzieva D; Tilkiyan E
    Folia Med (Plovdiv); 2021 Oct; 63(5):692-696. PubMed ID: 35851203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers.
    Sukocheva O; Menschikowski M; Hagelgans A; Yarla NS; Siegert G; Reddanna P; Bishayee A
    Semin Cancer Biol; 2019 Jun; 56():116-127. PubMed ID: 29104026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PLA2R and THSD7A: Disparate Paths to the Same Disease?
    Beck LH
    J Am Soc Nephrol; 2017 Sep; 28(9):2579-2589. PubMed ID: 28674044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy.
    Kim S; Chin HJ; Na KY; Kim S; Oh J; Chung W; Noh JW; Lee YK; Cho JT; Lee EK; Chae DW;
    Nephron Clin Pract; 2011; 117(3):c253-8. PubMed ID: 20805699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
    L'Imperio V; Pieruzzi F; Sinico RA; Nebuloni M; Granata A; Smith A; Radice A; Pagni F
    J Nephrol; 2018 Aug; 31(4):543-550. PubMed ID: 29626294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.
    Kanigicherla D; Gummadova J; McKenzie EA; Roberts SA; Harris S; Nikam M; Poulton K; McWilliam L; Short CD; Venning M; Brenchley PE
    Kidney Int; 2013 May; 83(5):940-8. PubMed ID: 23364522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenesis of membranous nephropathy: a new paradigm in evolution.
    Glassock RJ
    Contrib Nephrol; 2013; 181():131-42. PubMed ID: 23689575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T-cell epitopes of PLA2R1 in membranous nephropathy: another step toward antigen-based immunotherapies.
    Hoxha E
    Kidney Int; 2023 Mar; 103(3):466-469. PubMed ID: 36822752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.